Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biochem Biophys Res Commun ; 458(1): 180-5, 2015 Feb 27.
Artigo em Inglês | MEDLINE | ID: mdl-25640841

RESUMO

Human cytomegalovirus (HCMV) is a common and usually asymptomatic virus agent in healthy individuals. Initiation of HCMV productive infection depends on expression of the major immediate early (MIE) genes. The transcription of HCMV MIE genes is regulated by a diverse set of transcription factors. It was previously reported that productive HCMV infection is triggered probably by elevation of the plasma hydroxycorticoid level. However, it is poorly understood whether the transcription of MIE genes is directly regulated by glucocorticoid. Here, we found that the dexamethasone (DEX), a synthetic glucocorticoid, facilitates the transcription of HCMV MIE genes through the MIE promoter and enhancer in a glucocorticoid receptor (GR)-dependent manner. By competitive EMSA and reporter assays, we revealed that an NF-I like protein is involved in DEX-mediated transcriptional activation of the MIE promoter. Thus, this study supports a notion that the increased level of hydroxycorticoid in the third trimester of pregnancy reactivates HCMV virus production from the latent state.


Assuntos
Citomegalovirus/efeitos dos fármacos , Citomegalovirus/genética , Dexametasona/farmacologia , Genes Precoces , Fatores de Transcrição NFI/genética , Receptores de Glucocorticoides/genética , Sequência de Bases , Citomegalovirus/patogenicidade , Elementos Facilitadores Genéticos , Regulação Viral da Expressão Gênica , Glucocorticoides/farmacologia , Células HeLa/efeitos dos fármacos , Células HeLa/virologia , Humanos , Dados de Sequência Molecular , Fatores de Transcrição NFI/metabolismo , Regiões Promotoras Genéticas/efeitos dos fármacos , Sequências Repetitivas de Ácido Nucleico , Elementos de Resposta/genética
2.
J Obstet Gynaecol Res ; 35(5): 901-5, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20149039

RESUMO

AIM: We aimed to assess the efficacy and safety of midtrimester termination of pregnancy using gemeprost in combination with laminaria in women who had previously undergone cesarean section and in women who had not. METHODS: Between January 1999 and December 2006, we carried out a retrospective study of termination of pregnancy at 12-21 weeks of gestation at the University of Tsukuba Hospital. Termination of pregnancy was carried out by three-step uterine cervical dilation using laminaria followed by vaginal administration of 1 mg gemeprost every 3 h for up to four doses over 24 h. RESULTS: A total of 173 women underwent midtrimester termination of pregnancy. The women were categorized into two groups: those who had previously undergone cesarean section (n = 26) (previous cesarean section group) and those who had not (n = 147) (control group). Seven women had undergone cesarean section at least twice. The gemeprost dose administered was 2.8 +/- 1.4 mg for the previous cesarean section group and 2.4 +/- 1.6 mg for the control group (difference in doses not significant). Although abnormal vaginal bleeding (>500 mL) was more likely to occur in the previous cesarean section group than in the control group (odds ratio, 2.61; 95% confidence interval, 0.63-10.82), none of the woman required blood transfusion. Uterine rupture and failed abortion were not observed. CONCLUSION: The efficacy and safety of our laminaria-gemeprost protocol for termination of pregnancy during the midtrimester are similar for women who have previously undergone cesarean section and those who have not.


Assuntos
Aborto Induzido/métodos , Alprostadil/análogos & derivados , Laminaria , Abortivos não Esteroides/uso terapêutico , Administração Intravaginal , Adulto , Alprostadil/uso terapêutico , Cesárea , Distribuição de Qui-Quadrado , Feminino , Humanos , Gravidez , Segundo Trimestre da Gravidez , Estatísticas não Paramétricas , Resultado do Tratamento
3.
Int J Clin Oncol ; 10(6): 444-6, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16369752

RESUMO

Patients with ovarian cancer with clear cell histology often have venous thromboembolism (VTE) even before surgery. In view of the possible association between clear cell histology and VTE in endometrial cancer, we measured the plasma levels of thrombin-antithrombin III complex (TAT) and D-dimer (DD) in the preoperative examinations of a patient with clear cell adenocarcinoma of the endometrium. Plasma TAT and DD were both highly elevated, though the patient had no symptoms of VTE or risk factors such as obesity or diabetes mellitus. Ultrasound Doppler examination and lung perfusion scintigraphy just before surgery revealed a thrombosis in the left popliteal vein and a pulmonary embolism. After implanting an inferior vena cava filter to prevent a fatal embolism of the lung, we performed abdominal total hysterectomy, bilateral salpingo-oophorectomy, and sampling of the pelvic lymph nodes. The VTE gradually disappeared and the plasma levels of TAT and DD returned to normal after surgery. Possibly, the VTE in this patient may have been associated with the clear cell histology.


Assuntos
Adenocarcinoma de Células Claras/complicações , Neoplasias do Endométrio/complicações , Tromboembolia/complicações , Tromboembolia/diagnóstico , Adenocarcinoma de Células Claras/sangue , Adenocarcinoma de Células Claras/cirurgia , Idoso , Antitrombina III , Neoplasias do Endométrio/sangue , Neoplasias do Endométrio/cirurgia , Feminino , Produtos de Degradação da Fibrina e do Fibrinogênio/metabolismo , Humanos , Histerectomia , Ovariectomia , Peptídeo Hidrolases/sangue , Veia Poplítea , Cuidados Pré-Operatórios , Embolia Pulmonar/sangue , Embolia Pulmonar/complicações , Embolia Pulmonar/diagnóstico , Tromboembolia/sangue , Trombose Venosa/sangue , Trombose Venosa/complicações , Trombose Venosa/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...